RESULTS
2 matches
Article
AstraZeneca Drug Cuts Death Risk in Advanced Gastric Cancer
WILMINGTON, DE — AstraZeneca’s experimental cancer drug sonesitatug vedotin reduced the risk of death by 53% in patients receiving third-line or later treatment for advanced gastric and related…
Article
AstraZeneca Drug Combination Extends Lung Cancer Survival
WILMINGTON, DE — AstraZeneca’s IMFINZI combined with Amgen’s tarlatamab-dlle extended median survival to 21.1 months in patients with extensive-stage small cell lung cancer, compared with 12.7 months for…
EXPLORE
Browse sections
Article
AstraZeneca Drug Cuts Death Risk in Advanced Gastric Cancer
Article
Why a Top House Democrat Now Supports Impeaching Trump and Hegseth
Article
Ask Lisi: I saw my friends in a compromising position. Should I say something?
Article
AI, sex and swearing grannies: The 5 craziest ads of the 2026 midterms from across the country
Article
Jim Dey | Supreme Court appeal may be Madigan's last shot
Article
Jobs in Islamabad police: Here you can check list; names of newly recruited ASIs
Article
Early voting surges in St. Louis area compared to 2022
Article